SDCBP and neoplasm: This is because gain of syntenin expression in tumor cells has been invariably associated with the invasion and the metastatic potential of various solid tumors, including melanoma, glioblastoma, breast, prostate, and head/neck squamous cancers (Pradhan et al, 2020).